NUS
NU SKIN ENTERPRISES, INC.
Company overview
- Market capitalization
- $225.86M
- Employees
- 2,800
- Latest publication
- 2026-09-29
About NU SKIN ENTERPRISES, INC.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 320,112,000USD | 320,608,000USD | 370,320,000USD | 364,211,000USD | 386,138,000USD | 430,145,000USD | 417,306,000USD | 488,640,000USD |
| Cost Of Revenue | 101,787,000USD | 106,145,000USD | 108,339,000USD | 107,488,000USD | 120,405,000USD | 128,682,000USD | 123,242,000USD | 136,215,000USD |
| Gross Profit | 218,325,000USD | 214,463,000USD | 261,981,000USD | 256,723,000USD | 265,733,000USD | 301,463,000USD | 294,064,000USD | 352,425,000USD |
| Selling General Administrative | 90,847,000USD | 98,544,000USD | 107,395,000USD | 104,817,000USD | 106,725,000USD | 115,620,000USD | 124,566,000USD | 145,033,000USD |
| General And Administrative Expenses | 90,847,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 277,644,000USD | 208,598,000USD | 238,737,000USD | 235,081,000USD | 234,953,000USD | 283,232,000USD | 285,242,000USD | 336,362,000USD |
| Operating Income | -59,319,000USD | 5,865,000USD | 23,244,000USD | 21,642,000USD | 30,780,000USD | 18,231,000USD | 8,822,000USD | 16,063,000USD |
| Total Other Income Expense Net | -3,856,000USD | -3,266,000USD | -5,053,000USD | -5,648,000USD | -3,369,000USD | -4,933,000USD | -7,721,000USD | -6,735,000USD |
| Interest Expense | 3,322,000USD | 4,250,000USD | 3,994,000USD | 4,145,000USD | 2,526,000USD | 6,500,000USD | 7,325,000USD | 1,476,000USD |
| Income Before Tax | -63,175,000USD | 2,599,000USD | 18,191,000USD | 15,994,000USD | 27,411,000USD | 13,298,000USD | 1,101,000USD | 9,328,000USD |
| Income Tax Expense | 186,623,000USD | 763,000USD | 3,700,000USD | -1,085,000USD | 6,292,000USD | 4,996,000USD | 1,634,000USD | 2,046,000USD |
| Net Income | -249,798,000USD | 1,836,000USD | 14,491,000USD | 17,079,000USD | 21,119,000USD | 8,302,000USD | -533,000USD | 7,282,000USD |
| Selling And Marketing Expenses | — | 110,054,000USD | — | 130,264,000USD | 128,228,000USD | 167,612,000USD | 153,542,000USD | — |
| Net Interest Income | — | -4,250,000USD | -3,994,000USD | -4,145,000USD | -2,526,000USD | -6,500,000USD | -7,325,000USD | — |
| Tax Provision | — | 763,000USD | 3,700,000USD | -1,085,000USD | 6,292,000USD | 4,996,000USD | 1,634,000USD | 2,046,000USD |
| Net Income From Continuing Ops | — | 1,836,000USD | 14,491,000USD | 17,079,000USD | 21,119,000USD | 8,302,000USD | -533,000USD | 7,282,000USD |
| Ebit | — | 6,849,000USD | 22,185,000USD | 20,139,000USD | 29,937,000USD | 19,798,000USD | 8,426,000USD | 9,328,000USD |
| Ebitda | — | 19,191,000USD | 35,097,000USD | 32,230,000USD | 42,989,000USD | 37,119,000USD | 26,863,000USD | 26,589,000USD |
| Depreciation And Amortization | — | 12,342,000USD | 12,912,000USD | 12,091,000USD | 13,052,000USD | 17,321,000USD | 18,437,000USD | 17,261,000USD |
| Reconciled Depreciation | — | 12,342,000USD | 12,912,000USD | 12,091,000USD | 13,052,000USD | 17,321,000USD | 18,437,000USD | 18,584,000USD |
| Research Development | — | — | 10,800,000USD | — | — | — | — | 22,600,000USD |
| Unclassified Operating Expenses | — | — | 120,542,000USD | — | — | — | 7,134,000USD | 168,729,000USD |
| Interest Income | — | — | 3,994,000USD | 4,145,000USD | 2,526,000USD | 6,500,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | 14,491,000USD | 17,079,000USD | 21,119,000USD | 8,302,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,485,159,000USD | 1,969,131,000USD | 2,225,659,000USD | 2,695,669,000USD | 2,581,934,000USD | 2,420,416,000USD | 2,679,008,000USD | 2,279,099,000USD |
| Cost Of Revenue | 453,761,000USD | 611,850,000USD | 630,915,000USD | 675,223,000USD | 658,028,000USD | 581,420,000USD | 634,140,000USD | 502,078,000USD |
| Gross Profit | 1,031,398,000USD | 1,357,281,000USD | 1,594,744,000USD | 2,020,446,000USD | 1,923,906,000USD | 1,838,996,000USD | 2,044,868,000USD | 1,777,021,000USD |
| Selling General Administrative | 432,141,000USD | 546,858,000USD | 555,769,000USD | 666,395,000USD | 646,848,000USD | 615,970,000USD | 662,302,000USD | 564,514,000USD |
| Selling And Marketing Expenses | 508,380,000USD | 742,365,000USD | 879,634,000USD | 1,068,189,000USD | — | — | — | — |
| Total Operating Expenses | 940,521,000USD | 1,309,013,000USD | 1,483,897,000USD | 1,786,454,000USD | 1,666,342,000USD | 1,571,570,000USD | 1,733,322,000USD | 1,502,538,000USD |
| Operating Income | 90,877,000USD | 48,268,000USD | 110,847,000USD | 233,992,000USD | 257,564,000USD | 267,426,000USD | 240,860,000USD | 274,483,000USD |
| Interest Income | 42,048,000USD | 25,600,000USD | 13,500,000USD | 11,000,000USD | 13,100,000USD | 19,200,000USD | 21,800,000USD | 7,900,000USD |
| Interest Expense | 13,948,000USD | 25,560,000USD | 21,877,000USD | 11,000,000USD | 13,100,000USD | 19,200,000USD | 0USD | 0USD |
| Net Interest Income | -13,948,000USD | -25,560,000USD | -13,493,000USD | — | — | — | — | — |
| Income Before Tax | 196,197,000USD | 26,578,000USD | 88,970,000USD | 232,459,000USD | 256,232,000USD | 255,172,000USD | 219,666,000USD | 265,567,000USD |
| Income Tax Expense | 35,993,000USD | 17,983,000USD | -15,808,000USD | 85,193,000USD | 64,877,000USD | 81,619,000USD | 97,779,000USD | 136,130,000USD |
| Tax Provision | 35,993,000USD | -16,923,000USD | -15,808,000USD | 85,193,000USD | 64,877,000USD | 81,619,000USD | 97,779,000USD | 136,130,000USD |
| Net Income | 160,204,000USD | 8,595,000USD | 104,778,000USD | 147,266,000USD | 191,355,000USD | 173,553,000USD | 121,887,000USD | 129,437,000USD |
| Net Income From Continuing Ops | 160,204,000USD | 58,528,000USD | 104,778,000USD | 147,266,000USD | 191,355,000USD | 173,553,000USD | 121,887,000USD | 129,437,000USD |
| Ebit | 210,145,000USD | 133,758,000USD | 102,463,000USD | 243,459,000USD | 257,564,000USD | 267,426,000USD | 219,666,000USD | 274,483,000USD |
| Ebitda | 262,406,000USD | 202,981,000USD | 174,969,000USD | 368,483,000USD | 331,555,000USD | 344,076,000USD | 302,669,000USD | 346,047,000USD |
| Depreciation And Amortization | 52,261,000USD | 69,223,000USD | 72,506,000USD | 125,024,000USD | 73,991,000USD | 76,650,000USD | 83,003,000USD | 71,564,000USD |
| Reconciled Depreciation | 52,261,000USD | 70,910,000USD | 72,506,000USD | 76,320,000USD | 73,991,000USD | 76,650,000USD | 83,003,000USD | 71,564,000USD |
| Total Other Income Expense Net | 105,320,000USD | -21,690,000USD | -21,877,000USD | -1,533,000USD | -1,332,000USD | -12,254,000USD | -21,194,000USD | -8,916,000USD |
| Net Income Applicable To Common Shares | 160,204,000USD | 8,595,000USD | 104,778,000USD | 147,266,000USD | 191,355,000USD | 173,553,000USD | 121,887,000USD | 129,437,000USD |
| Research Development | — | 22,600,000USD | 23,300,000USD | 27,200,000USD | 23,300,000USD | 30,100,000USD | 23,000,000USD | 22,000,000USD |
| Unclassified Operating Expenses | — | — | 25,194,000USD | 24,670,000USD | 996,194,000USD | 925,500,000USD | 1,048,020,000USD | 916,024,000USD |
| Non Operating Income Net Other | — | — | -21,877,000USD | -1,533,000USD | -1,332,000USD | -12,254,000USD | -21,194,000USD | -8,916,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,121,530,000USD | 1,376,798,000USD | 1,405,313,000USD | 1,424,406,000USD | 1,443,693,000USD | 1,391,411,000USD | 1,468,914,000USD | 1,582,895,000USD |
| Cash And Equivalents | 189,643,000USD | — | 238,630,000USD | 251,787,000USD | 264,159,000USD | 203,770,000USD | 186,883,000USD | 227,751,000USD |
| Cash And Short Term Investments | 191,386,000USD | 200,405,000USD | 239,841,000USD | 252,997,000USD | 264,159,000USD | 213,551,000USD | 197,994,000USD | 237,828,000USD |
| Short Term Investments | 1,743,000USD | 1,751,000USD | 1,211,000USD | 1,210,000USD | 1,211,000USD | 9,781,000USD | 11,111,000USD | 10,077,000USD |
| Total Current Assets | 508,149,000USD | 522,888,000USD | 547,698,000USD | 548,143,000USD | 571,553,000USD | 524,857,000USD | 538,599,000USD | 653,371,000USD |
| Other Current Assets | 76,364,000USD | 98,870,000USD | 84,714,000USD | 67,721,000USD | 67,314,000USD | 65,954,000USD | 99,579,000USD | 98,942,000USD |
| Other Non Current Assets | 125,755,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 578,791,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 256,347,000USD | 256,997,000USD | 263,733,999USD | 254,437,000USD | 283,906,000USD | 260,300,000USD | 296,607,000USD | 339,351,000USD |
| Other Current Liabilities | 198,636,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 78,705,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 542,739,000USD | 794,087,000USD | 805,240,000USD | 799,795,000USD | 787,754,000USD | 753,969,000USD | 651,455,000USD | 706,875,000USD |
| Total Equity Including Noncontrolling Interest | 542,739,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 20,000,000USD | 20,000,000USD | 20,000,000USD | 20,000,000USD | 35,000,000USD | 20,000,000USD | 30,000,000USD | 60,000,000USD |
| Long Term Debt | 193,664,000USD | 203,593,000USD | 204,187,000USD | 209,044,000USD | 213,900,000USD | 218,757,000USD | 363,613,000USD | 373,470,000USD |
| Deferred Revenue | 6,300,000USD | — | — | — | — | — | — | — |
| Net Receivables | 48,902,000USD | 45,013,000USD | 39,544,000USD | 48,892,000USD | 59,703,000USD | 56,576,000USD | 50,784,000USD | 68,812,000USD |
| Inventory | 191,497,000USD | 178,600,000USD | 183,599,000USD | 178,533,000USD | 180,377,000USD | 188,776,000USD | 190,242,000USD | 247,789,000USD |
| Property Plant Equipment Net | 444,992,000USD | 451,960,000USD | 458,875,000USD | 455,213,000USD | 451,943,000USD | 459,456,000USD | 466,908,000USD | 496,223,000USD |
| Goodwill | 4,750,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 37,884,000USD | 39,290,000USD | 42,614,000USD | 44,198,000USD | 45,937,000USD | 47,554,000USD | 74,278,000USD | 85,266,000USD |
| Accounts Payable | 37,711,000USD | 28,815,000USD | 26,183,000USD | 28,523,000USD | 28,734,000USD | 33,590,000USD | 34,880,000USD | 32,736,000USD |
| Common Stock | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD |
| Retained Earnings | 1,606,571,000USD | 1,859,282,000USD | 1,860,319,000USD | 1,848,734,000USD | 1,834,617,000USD | 1,816,462,000USD | 1,711,949,000USD | 1,751,037,000USD |
| Accumulated Other Comprehensive Income | -118,152,000USD | -236,754,000USD | -116,105,000USD | -116,916,000USD | -114,058,000USD | -123,850,000USD | -124,758,000USD | -105,040,000USD |
| Total Liab | — | 582,711,000USD | 600,073,000USD | 624,611,000USD | 655,939,000USD | 637,442,000USD | 817,459,000USD | 876,020,000USD |
| Other Current Liab | — | 201,982,000USD | 199,110,999USD | 198,614,000USD | 212,772,000USD | 206,710,000USD | 175,977,000USD | 246,615,000USD |
| Capital Stock | — | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD |
| Good Will | — | 83,625,000USD | 83,625,000USD | 83,625,000USD | 83,625,000USD | 83,625,000USD | 83,625,000USD | 99,885,000USD |
| Cash | — | 198,654,000USD | 238,630,000USD | 251,787,000USD | 264,159,000USD | 203,770,000USD | 186,883,000USD | 227,751,000USD |
| Current Deferred Revenue | — | 6,200,000USD | — | 7,300,000USD | 7,400,000USD | — | 15,688,000USD | — |
| Net Debt | — | 78,956,000USD | 125,623,000USD | 39,639,000USD | 46,578,000USD | 96,936,000USD | 291,342,000USD | 274,070,000USD |
| Short Term Debt | — | 20,000,000USD | 38,440,000USD | 20,000,000USD | 35,000,000USD | 20,000,000USD | 47,922,000USD | 60,000,000USD |
| Short Long Term Debt Total | — | 277,610,000USD | 364,253,000USD | 291,426,000USD | 310,737,000USD | 300,706,000USD | 478,225,000USD | 501,821,000USD |
| Property Plant Equipment Gross | — | 451,960,000USD | 862,086,000USD | 455,213,000USD | 451,943,000USD | 459,456,000USD | 819,863,000USD | 496,223,000USD |
| Common Stock Shares Outstanding | — | 49,422,000shares | 49,912,000shares | 50,310,000shares | 49,499,000shares | 50,328,000shares | 49,712,000shares | 49,733,000shares |
| Non Current Assets Total | — | 853,910,000USD | 857,615,000USD | 876,262,999USD | 872,140,000USD | 866,554,000USD | 930,315,000USD | 929,524,000USD |
| Non Current Liabilities Total | — | 325,714,000USD | 336,339,000USD | 370,174,000USD | 372,033,000USD | 377,142,000USD | 520,852,000USD | 536,669,000USD |
| Non Current Liabilities Other | — | 68,104,000USD | 7,132,000USD | 98,748,000USD | 96,296,000USD | 96,436,000USD | 7,478,000USD | 94,848,000USD |
| Non Currrent Assets Other | — | 279,035,000USD | 253,756,000USD | 293,226,999USD | 290,635,000USD | 275,919,000USD | 91,665,000USD | 248,150,000USD |
| Net Working Capital | — | 265,891,000USD | 283,964,000USD | 293,706,000USD | 287,647,000USD | 264,557,000USD | 241,992,000USD | 314,020,000USD |
| Unclassified Current Liabilities | — | -20,000,000USD | -20,000,000USD | -20,000,000USD | -35,000,000USD | -20,000,000USD | -7,860,000USD | -60,000,000USD |
| Unclassified Non Current Liabilities | — | 54,017,000USD | 125,020,000USD | 62,382,000USD | 61,837,000USD | 61,949,000USD | 149,761,000USD | 68,351,000USD |
| Unclassified Equity | — | -828,623,000USD | -939,156,000USD | -932,205,000USD | -932,987,000USD | -938,825,000USD | -935,918,000USD | -939,304,000USD |
| Other Assets | — | — | 280,187,000USD | 293,227,000USD | 290,635,000USD | 275,919,000USD | 320,212,000USD | 248,150,000USD |
| Long Term Investments | — | — | 18,745,000USD | — | — | — | 39,590,000USD | — |
| Unclassified Non Current Assets | — | — | -280,187,000USD | -293,227,000USD | -290,635,000USD | -275,919,000USD | -145,963,000USD | -248,150,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,405,313,000USD | 1,468,914,000USD | 1,806,463,000USD | 1,820,970,000USD | 1,906,480,000USD | 1,957,076,000USD | 1,769,006,000USD | 1,694,446,000USD |
| Intangible Assets | 42,614,000USD | 74,278,000USD | 105,309,000USD | 66,701,000USD | 76,991,000USD | 89,532,000USD | 80,321,000USD | 89,989,000USD |
| Other Current Assets | 89,670,000USD | 99,579,000USD | 81,198,000USD | 87,816,000USD | 76,906,000USD | 101,563,000USD | 69,854,000USD | 51,877,000USD |
| Total Liab | 600,073,000USD | 817,459,000USD | 984,495,000USD | 923,674,000USD | 993,708,000USD | 1,062,805,000USD | 893,717,000USD | 912,579,000USD |
| Total Stockholder Equity | 805,240,000USD | 651,455,000USD | 821,968,000USD | 897,296,000USD | 912,772,000USD | 894,271,000USD | 875,289,000USD | 781,867,000USD |
| Other Current Liab | 199,111,000USD | 175,977,000USD | 195,227,000USD | 202,029,000USD | 274,500,000USD | 307,708,000USD | 201,113,000USD | 257,112,000USD |
| Common Stock | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD |
| Capital Stock | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD | 91,000USD |
| Retained Earnings | 1,860,319,000USD | 1,711,949,000USD | 1,870,470,000USD | 1,939,497,000USD | 1,911,734,000USD | 1,840,740,000USD | 1,727,772,000USD | 1,635,751,000USD |
| Good Will | 83,625,000USD | 83,625,000USD | 230,768,000USD | 206,432,000USD | 206,432,000USD | 202,979,000USD | 196,573,000USD | 196,573,000USD |
| Other Assets | 253,756,000USD | 271,081,000USD | 197,899,000USD | 244,429,000USD | 175,460,000USD | 293,186,000USD | 154,016,000USD | 144,112,000USD |
| Cash | 238,630,000USD | 186,883,000USD | 256,057,000USD | 264,725,000USD | 339,593,000USD | 402,683,000USD | 335,630,000USD | 386,911,000USD |
| Cash And Equivalents | 238,630,000USD | 186,883,000USD | 256,057,000USD | 264,725,000USD | 339,593,000USD | 402,683,000USD | 335,630,000USD | 386,911,000USD |
| Cash And Short Term Investments | 239,841,000USD | 197,994,000USD | 267,816,000USD | 278,509,000USD | 354,814,000USD | 423,899,000USD | 344,043,000USD | 398,257,000USD |
| Total Current Assets | 547,698,000USD | 538,599,000USD | 701,871,000USD | 759,868,000USD | 872,950,000USD | 903,198,000USD | 740,166,000USD | 799,237,000USD |
| Total Current Liabilities | 263,734,000USD | 296,607,000USD | 328,871,000USD | 359,243,000USD | 529,694,000USD | 542,856,000USD | 356,760,000USD | 439,655,000USD |
| Net Debt | 125,623,000USD | 291,342,000USD | 351,273,000USD | 255,797,000USD | 164,192,000USD | 97,694,000USD | 171,381,000USD | 43,552,000USD |
| Short Term Debt | 38,440,000USD | 47,922,000USD | 48,898,000USD | 54,376,000USD | 140,927,000USD | 74,981,000USD | 66,849,000USD | 69,455,000USD |
| Short Long Term Debt | 20,000,000USD | 30,000,000USD | 25,000,000USD | 25,000,000USD | 107,500,000USD | 30,000,000USD | 27,500,000USD | 69,455,000USD |
| Short Long Term Debt Total | 364,253,000USD | 478,225,000USD | 607,330,000USD | 520,522,000USD | 503,785,000USD | 500,377,000USD | 507,011,000USD | 430,463,000USD |
| Long Term Debt | 204,187,000USD | 363,613,000USD | 478,040,000USD | 377,466,000USD | 268,781,000USD | 305,393,000USD | 334,461,000USD | 361,008,000USD |
| Long Term Investments | 18,745,000USD | 39,590,000USD | 36,374,000USD | 39,493,000USD | 35,868,000USD | 11,344,000USD | — | — |
| Short Term Investments | 1,211,000USD | 11,111,000USD | 11,759,000USD | 13,784,000USD | 15,221,000USD | 21,216,000USD | 8,413,000USD | 11,346,000USD |
| Net Receivables | 39,544,000USD | 50,784,000USD | 72,879,000USD | 47,360,000USD | 41,299,000USD | 63,370,000USD | 50,378,000USD | 53,282,000USD |
| Inventory | 178,643,000USD | 190,242,000USD | 279,978,000USD | 346,183,000USD | 399,931,000USD | 314,366,000USD | 275,891,000USD | 295,821,000USD |
| Accounts Payable | 26,183,000USD | 34,880,000USD | 43,113,000USD | 53,963,000USD | 49,993,000USD | 66,174,000USD | 38,979,000USD | 47,617,000USD |
| Property Plant Equipment Net | 451,189,000USD | 466,908,000USD | 523,072,000USD | 571,671,000USD | 598,245,000USD | 653,453,000USD | 644,824,000USD | 464,535,000USD |
| Property Plant Equipment Gross | 862,086,000USD | 819,863,000USD | 897,613,000USD | 444,806,000USD | 453,674,000USD | 653,453,000USD | 597,930,000USD | 464,535,000USD |
| Accumulated Other Comprehensive Income | -116,105,000USD | -124,758,000USD | -100,006,000USD | -86,509,000USD | -73,896,000USD | -64,768,000USD | -85,292,000USD | -79,934,000USD |
| Common Stock Shares Outstanding | 50,301,000shares | 49,662,000shares | 49,860,000shares | 50,525,000shares | 51,427,000shares | 52,765,000shares | 55,927,000shares | 56,476,000shares |
| Non Current Assets Total | 857,615,000USD | 930,315,000USD | 1,104,592,000USD | 1,061,102,000USD | 1,033,530,000USD | 1,053,878,000USD | 1,028,840,000USD | 895,209,000USD |
| Non Current Liabilities Total | 336,339,000USD | 520,852,000USD | 655,624,000USD | 564,431,000USD | 464,014,000USD | 519,949,000USD | 536,957,000USD | 472,924,000USD |
| Non Current Liabilities Other | 7,132,000USD | 7,478,000USD | 8,950,000USD | 76,540,000USD | 88,759,000USD | 112,275,000USD | 105,701,000USD | 27,768,000USD |
| Non Currrent Assets Other | 261,442,000USD | 91,665,000USD | 99,806,000USD | 87,035,000USD | 89,511,000USD | 61,156,000USD | 76,342,000USD | 144,112,000USD |
| Net Working Capital | 283,964,000USD | 241,992,000USD | 373,000,000USD | 400,625,000USD | 343,256,000USD | 360,342,000USD | 383,406,000USD | 359,582,000USD |
| Unclassified Non Current Assets | -253,756,000USD | -96,832,000USD | -88,636,000USD | -154,659,000USD | -148,977,000USD | -257,772,000USD | -123,236,000USD | -144,112,000USD |
| Unclassified Current Liabilities | -20,000,000USD | -7,860,000USD | -3,755,000USD | — | -76,365,000USD | 28,939,000USD | — | -24,088,000USD |
| Unclassified Non Current Liabilities | 125,020,000USD | 149,761,000USD | 168,634,000USD | 12,140,000USD | — | — | — | -27,768,000USD |
| Unclassified Equity | -939,156,000USD | -935,918,000USD | -948,678,000USD | -955,874,000USD | 601,612,000USD | 579,710,000USD | 557,453,000USD | 552,473,000USD |
| Current Deferred Revenue | — | 15,688,000USD | 20,388,000USD | 27,053,000USD | 33,139,000USD | 35,054,000USD | 20,162,000USD | 20,104,000USD |
| Other Liab | — | — | — | 98,285,000USD | 106,474,000USD | 102,281,000USD | 96,795,000USD | 111,916,000USD |
| Net Tangible Assets | — | — | — | 897,296,000USD | 912,772,000USD | 894,271,000USD | 875,289,000USD | 781,867,000USD |
| Treasury Stock | — | — | — | — | -1,526,860,000USD | -1,461,593,000USD | -1,324,826,000USD | -1,326,605,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 25,000,000USD |
| Stock Based Compensation | 4,812,000USD |
| Change To Account Receivables | -10,007,000USD |
| Change To Inventory | -21,260,000USD |
| Change To Liabilities | -17,606,000USD |
| Change In Working Capital | -10,161,000USD |
| Operating Cash Flow | 6,706,000USD |
| Capital Expenditures | -19,352,000USD |
| Net Investments | -573,000USD |
| Investing Cash Flow | -19,925,000USD |
| Net Debt Issuance | -10,978,000USD |
| Net Common Stock Issuance | -5,011,000USD |
| Common Dividends Paid | -5,786,000USD |
| Other Financing Activities | -6,500,000USD |
| Unclassified Financing Cash Flow | -5,505,000USD |
| Financing Cash Flow | -33,780,000USD |
| Effect Of Forex Changes On Cash | -1,988,000USD |
| Change In Cash | -48,987,000USD |
| End Cash Flow | 189,643,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,836,000USD | 14,491,000USD | 17,079,000USD | 21,119,000USD | 107,515,000USD | -36,105,000USD | 8,302,000USD | -118,258,000USD |
| Depreciation | 12,342,000USD | 12,912,000USD | 12,091,000USD | 13,052,000USD | 14,206,000USD | 16,449,000USD | 17,321,000USD | 17,603,000USD |
| Stock Based Compensation | 3,695,000USD | 3,160,000USD | 5,819,000USD | 5,818,000USD | 9,308,000USD | 3,445,000USD | 3,490,000USD | 3,646,000USD |
| Other Non Cash Items | 11,956,000USD | 14,493,999USD | 8,742,000USD | 10,712,000USD | -112,459,000USD | 79,516,000USD | -28,389,000USD | 155,874,000USD |
| Change To Account Receivables | -5,737,000USD | 8,737,000USD | 9,978,000USD | -2,782,000USD | -5,878,000USD | -12,837,000USD | 3,680,000USD | -6,053,000USD |
| Change To Inventory | -5,882,000USD | 884,000USD | 94,000USD | 10,941,000USD | -32,000USD | 5,370,000USD | 2,012,000USD | 15,937,000USD |
| Change In Working Capital | -35,471,000USD | -28,436,000USD | -14,889,000USD | -7,482,000USD | -18,812,000USD | 10,332,000USD | 36,019,000USD | -3,996,000USD |
| Total Cash From Operating Activities | -3,919,000USD | 16,620,999USD | 27,481,000USD | 35,795,000USD | 389,000USD | 25,785,000USD | 31,432,000USD | 51,207,000USD |
| Capital Expenditures | -13,714,000USD | -10,760,000USD | -9,915,000USD | -18,000USD | -13,584,000USD | -12,583,000USD | -8,596,000USD | -8,123,000USD |
| Free Cash Flow | -17,633,000USD | 5,860,999USD | 17,566,000USD | 35,777,000USD | -13,195,000USD | 13,202,000USD | 22,836,000USD | 43,084,000USD |
| Investments | -573,000USD | 0USD | -9,915,000USD | 8,793,000USD | 181,544,000USD | -13,622,000USD | -6,547,000USD | -8,531,000USD |
| Total Cashflows From Investing Activities | -14,287,000USD | -9,760,000USD | -9,915,000USD | 8,793,000USD | 181,544,000USD | -13,622,000USD | -6,547,000USD | -8,531,000USD |
| Net Borrowings | -489,000USD | -5,483,000USD | -20,635,000USD | 9,501,000USD | -155,621,000USD | -40,584,000USD | -25,742,000USD | — |
| Total Cash From Financing Activities | -20,399,000USD | -18,501,000USD | -26,876,000USD | 9,268,000USD | -166,295,000USD | -43,626,000USD | -28,778,000USD | -28,817,000USD |
| Dividends Paid | -2,873,000USD | -2,906,000USD | -2,962,000USD | -2,964,000USD | -3,002,000USD | -2,983,000USD | -2,983,000USD | -2,982,000USD |
| Sale Purchase Of Stock | -5,011,000USD | -10,020,000USD | -5,037,000USD | 20,000USD | -5,012,000USD | 2,004,000USD | -53,000USD | -60,000USD |
| Change In Cash | -39,976,000USD | -13,157,000USD | -12,372,000USD | 60,389,000USD | 16,887,000USD | -40,868,000USD | 3,501,000USD | 11,718,000USD |
| Begin Period Cash Flow | 238,630,000USD | 251,787,000USD | 264,159,000USD | 203,770,000USD | 186,883,000USD | 227,751,000USD | 224,250,000USD | 212,532,000USD |
| End Period Cash Flow | 198,654,000USD | 238,630,000USD | 251,787,000USD | 264,159,000USD | 203,770,000USD | 186,883,000USD | 227,751,000USD | 224,250,000USD |
| Other Cashflows From Financing Activities | -10,657,000USD | -418,000USD | 1,758,000USD | 2,711,000USD | -2,660,000USD | -2,886,000USD | -53,000USD | -60,000USD |
| Unclassified Operating Cash Flow | 1,723,000USD | — | -1,361,000USD | -7,424,000USD | — | -47,852,000USD | -5,311,000USD | -3,662,000USD |
| Unclassified Financing Cash Flow | -1,369,000USD | — | — | — | — | — | — | -25,715,000USD |
| Other Cashflows From Investing Activities | — | 1,000,000USD | 193,725,000USD | 203,939,000USD | 193,725,000USD | 3,621,000USD | 1USD | -408,000USD |
| Unclassified Investing Cash Flow | — | — | -183,810,000USD | -203,921,000USD | -180,141,000USD | 8,962,000USD | 8,595,999USD | 8,531,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 160,204,000USD | -146,594,000USD | 8,595,000USD | 104,778,000USD | 147,266,000USD | 191,355,000USD | 173,553,000USD | 121,887,000USD |
| Depreciation | 52,261,000USD | 69,810,000USD | 70,923,000USD | 72,506,000USD | 76,320,000USD | 73,991,000USD | 76,650,000USD | 83,003,000USD |
| Stock Based Compensation | 24,105,000USD | 14,823,000USD | 15,646,000USD | 12,367,000USD | 23,194,000USD | 24,060,000USD | 9,909,000USD | 26,609,000USD |
| Other Non Cash Items | -86,685,000USD | 257,515,000USD | 123,248,000USD | 62,712,000USD | 82,601,000USD | 49,085,000USD | 48,289,000USD | 58,052,000USD |
| Change To Account Receivables | 10,055,000USD | -7,763,000USD | -22,679,000USD | -11,449,000USD | 20,219,000USD | -11,207,000USD | 2,746,000USD | -10,453,000USD |
| Change To Inventory | 11,887,000USD | 30,318,000USD | -13,222,000USD | 40,314,000USD | -95,320,000USD | -31,137,000USD | 18,446,000USD | -33,371,000USD |
| Change In Working Capital | -69,619,000USD | -28,335,000USD | -81,683,000USD | -92,675,000USD | -193,620,000USD | 52,564,000USD | -132,435,000USD | -71,884,000USD |
| Total Cash From Operating Activities | 80,286,000USD | 111,742,000USD | 118,639,000USD | 108,062,000USD | 141,582,000USD | 379,141,000USD | 177,931,000USD | 202,738,000USD |
| Capital Expenditures | -34,277,000USD | -41,583,000USD | -58,490,000USD | -59,056,000USD | -68,615,000USD | -63,823,000USD | -66,067,000USD | -70,371,000USD |
| Free Cash Flow | 46,009,000USD | 70,159,000USD | 60,149,000USD | 49,006,000USD | 72,967,000USD | 315,318,000USD | 111,864,000USD | 132,367,000USD |
| Investments | 10,214,000USD | -37,962,000USD | -132,488,000USD | -8,023,000USD | -1,148,000USD | -656,000USD | 2,728,000USD | 116,000USD |
| Total Cashflows From Investing Activities | 170,662,000USD | -37,962,000USD | -134,501,000USD | -67,079,000USD | -88,726,000USD | -79,428,000USD | -71,412,000USD | -108,761,000USD |
| Net Borrowings | -172,238,000USD | -112,886,000USD | 96,802,000USD | 22,423,000USD | 40,000,000USD | -27,500,000USD | -69,455,000USD | 22,655,000USD |
| Total Cash From Financing Activities | -202,404,000USD | -133,176,000USD | 10,730,000USD | -99,504,000USD | -104,702,000USD | -245,166,000USD | -154,794,000USD | -116,714,000USD |
| Dividends Paid | -11,834,000USD | -11,927,000USD | -77,622,000USD | -77,015,000USD | -76,272,000USD | -78,387,000USD | -82,189,000USD | -80,581,000USD |
| Sale Purchase Of Stock | -20,040,000USD | -2,063,000USD | -13,011,000USD | -70,045,000USD | -80,420,000USD | -144,334,000USD | -825,000USD | -69,565,000USD |
| Change In Cash | 51,747,000USD | -69,174,000USD | -8,668,000USD | -74,868,000USD | -63,090,000USD | 67,053,000USD | -51,281,000USD | -39,488,000USD |
| Begin Period Cash Flow | 186,883,000USD | 256,057,000USD | 264,725,000USD | 339,593,000USD | 402,683,000USD | 335,630,000USD | 386,911,000USD | 426,399,000USD |
| End Period Cash Flow | 238,630,000USD | 186,883,000USD | 256,057,000USD | 264,725,000USD | 339,593,000USD | 402,683,000USD | 335,630,000USD | 386,911,000USD |
| Other Cashflows From Investing Activities | 194,725,000USD | 3,621,000USD | -76,011,000USD | -8,023,000USD | -18,963,000USD | -14,949,000USD | -8,073,000USD | 116,000USD |
| Other Cashflows From Financing Activities | 1,382,000USD | -6,300,000USD | -3,198,000USD | 481,975,000USD | 168,861,000USD | 120,764,000USD | 142,675,000USD | 3,534,000USD |
| Unclassified Operating Cash Flow | — | -55,477,000USD | -18,090,000USD | -51,626,000USD | 5,821,000USD | -11,914,000USD | 1,965,000USD | -14,929,000USD |
| Unclassified Investing Cash Flow | — | 37,962,000USD | 132,488,000USD | 8,023,000USD | — | — | — | -38,622,000USD |
| Unclassified Financing Cash Flow | — | — | 7,759,000USD | -456,842,000USD | -156,871,000USD | -115,709,000USD | -145,000,000USD | 7,243,000USD |
| Change To Liabilities | — | — | — | -127,397,000USD | -113,859,000USD | 126,677,000USD | -69,083,000USD | -27,411,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -58,521,000USD | -63,090,000USD | 67,053,000USD | -51,281,000USD | -39,488,000USD |
| Exchange Rate Changes | — | — | — | — | -11,244,000USD | 12,506,000USD | -3,006,000USD | -16,751,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | Beauty | 568,113,000 | USD | 0001140361-26-005130 |
| FY 2025Yearly · 2025-12-31 | Product | Other Product Lines | 227,984,000 | USD | 0001140361-26-005130 |
| FY 2025Yearly · 2025-12-31 | Product | Wellness | 689,062,000 | USD | 0001140361-26-005130 |
| FY 2024Yearly · 2024-12-31 | Product | Beauty | 681,765,000 | USD | 0001140361-26-005130 |
| FY 2024Yearly · 2024-12-31 | Product | Other Product Lines | 293,102,000 | USD | 0001140361-26-005130 |
| FY 2024Yearly · 2024-12-31 | Product | Wellness | 757,217,000 | USD | 0001140361-26-005130 |
| FY 2023Yearly · 2023-12-31 | Product | Beauty | 858,625,000 | USD | 0001140361-26-005130 |
| FY 2023Yearly · 2023-12-31 | Product | Other Product Lines | 224,413,000 | USD | 0001140361-26-005130 |
| FY 2023Yearly · 2023-12-31 | Product | Wellness | 886,093,000 | USD | 0001140361-26-005130 |
| FY 2022Yearly · 2022-12-31 | Product | Beauty | 1,069,714,000 | USD | 0001140361-25-004907 |
| FY 2022Yearly · 2022-12-31 | Product | Other Product Lines | 163,607,000 | USD | 0001140361-25-004907 |
| FY 2022Yearly · 2022-12-31 | Product | Wellness | 992,338,000 | USD | 0001140361-25-004907 |
| FY 2021Yearly · 2021-12-31 | Product | Beauty | 1,442,659,000 | USD | 0001140361-24-008111 |
| FY 2021Yearly · 2021-12-31 | Product | Other Product Lines | 190,461,000 | USD | 0001140361-24-008111 |
| FY 2021Yearly · 2021-12-31 | Product | Wellness | 1,062,549,000 | USD | 0001140361-24-008111 |
| FY 2020Yearly · 2020-12-31 | Product | Beauty | 1,491,803,000 | USD | 0001140361-23-007348 |
| FY 2020Yearly · 2020-12-31 | Product | Other Product Lines | 167,578,000 | USD | 0001140361-23-007348 |
| FY 2020Yearly · 2020-12-31 | Product | Wellness | 922,553,000 | USD | 0001140361-23-007348 |
| FY 2019Yearly · 2019-12-31 | Product | Other Product Lines | 133,806,000 | USD | 0001140361-21-004212 |
| FY 2019Yearly · 2019-12-31 | Product | Personal Care | 1,423,485,000 | USD | 0001140361-21-004212 |
| FY 2019Yearly · 2019-12-31 | Product | Wellness | 863,125,000 | USD | 0001140361-21-004212 |
| Q2 2019Quarterly · 2019-06-30 | Geography | Americas Pacific | 92,841,000 | USD | 0001140361-19-014385 |
| Q2 2019Quarterly · 2019-06-30 | Geography | China | 185,333,000 | USD | 0001140361-19-014385 |
| Q2 2019Quarterly · 2019-06-30 | Geography | EMEA | 43,400,000 | USD | 0001140361-19-014385 |
| Q2 2019Quarterly · 2019-06-30 | Geography | Hong Kong Taiwan | 43,712,000 | USD | 0001140361-19-014385 |
| Q2 2019Quarterly · 2019-06-30 | Geography | Japan | 65,251,000 | USD | 0001140361-19-014385 |
| Q2 2019Quarterly · 2019-06-30 | Geography | Other | 1,249,000 | USD | 0001140361-19-014385 |
| Q2 2019Quarterly · 2019-06-30 | Geography | South Korea | 84,732,000 | USD | 0001140361-19-014385 |
| Q2 2019Quarterly · 2019-06-30 | Geography | Southeast Asia | 75,395,000 | USD | 0001140361-19-014385 |
| Q1 2019Quarterly · 2019-03-31 | Geography | Americas Pacific | 86,456,000 | USD | 0001140361-19-008097 |
| Q1 2019Quarterly · 2019-03-31 | Geography | China | 208,488,000 | USD | 0001140361-19-008097 |
| Q1 2019Quarterly · 2019-03-31 | Geography | EMEA | 41,818,000 | USD | 0001140361-19-008097 |
| Q1 2019Quarterly · 2019-03-31 | Geography | Hong Kong Taiwan | 40,558,000 | USD | 0001140361-19-008097 |
| Q1 2019Quarterly · 2019-03-31 | Geography | Japan | 62,109,000 | USD | 0001140361-19-008097 |
| Q1 2019Quarterly · 2019-03-31 | Geography | South Korea | 83,853,000 | USD | 0001140361-19-008097 |
| Q1 2019Quarterly · 2019-03-31 | Geography | Southeast Asia | 72,495,000 | USD | 0001140361-19-008097 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Corporate | -1,426,000 | USD | 0001140361-20-010880 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Grow Tech | 0 | USD | 0001140361-20-010880 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Manufacturing | 35,172,000 | USD | 0001140361-20-010880 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Nu Skin | 594,351,000 | USD | 0001140361-20-010880 |
| FY 2018Yearly · 2018-12-31 | Product | Other Product Lines | 97,943,000 | USD | 0001140361-21-004212 |
| FY 2018Yearly · 2018-12-31 | Product | Personal Care | 1,659,737,000 | USD | 0001140361-21-004212 |
| FY 2018Yearly · 2018-12-31 | Product | Wellness | 921,328,000 | USD | 0001140361-21-004212 |
| Q4 2018Quarterly · 2018-12-31 | Product | Nu Skin | 422,190,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Product | Other Product Lines | 27,558,000 | USD | Legacy provider |
| Q4 2018Quarterly · 2018-12-31 | Product | Pharmanex | 233,539,000 | USD | Legacy provider |
| Q3 2018Quarterly · 2018-09-30 | Geography | Americas Pacific | 93,580,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Geography | China | 226,645,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Geography | EMEA | 42,819,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Geography | Hong Kong Taiwan | 44,949,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Geography | Japan | 63,649,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Geography | Other | 1,378,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Geography | South Korea | 89,963,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Geography | Southeast Asia | 86,307,000 | USD | 0001140361-19-019870 |
| Q3 2018Quarterly · 2018-09-30 | Product | Nu Skin | 384,635,000 | USD | 0001140361-18-042662 |
| Q3 2018Quarterly · 2018-09-30 | Product | Other Product Lines | 28,785,000 | USD | 0001140361-18-042662 |
| Q3 2018Quarterly · 2018-09-30 | Product | Pharmanex | 261,892,000 | USD | 0001140361-18-042662 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Americas Pacific | 103,990,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Geography | China | 245,256,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Geography | EMEA | 44,010,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Hong Kong Taiwan | 52,206,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Japan | 64,113,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Other | 1,030,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Geography | South Korea | 91,624,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Southeast Asia | 79,223,000 | USD | 0001140361-19-014385 |
| Q2 2018Quarterly · 2018-06-30 | Product | Nu Skin | 466,462,000 | USD | 0001021561-18-000115 |
| Q2 2018Quarterly · 2018-06-30 | Product | Other Product Lines | 24,730,000 | USD | 0001021561-18-000115 |
| Q2 2018Quarterly · 2018-06-30 | Product | Pharmanex | 212,998,000 | USD | 0001021561-18-000115 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Americas Pacific | 92,289,000 | USD | 0001140361-19-008097 |
| Q1 2018Quarterly · 2018-03-31 | Geography | China | 197,531,000 | USD | 0001140361-19-008097 |
| Q1 2018Quarterly · 2018-03-31 | Geography | EMEA | 44,981,000 | USD | 0001140361-19-008097 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Hong Kong Taiwan | 40,992,000 | USD | 0001140361-19-008097 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Japan | 63,224,000 | USD | 0001140361-19-008097 |
| Q1 2018Quarterly · 2018-03-31 | Geography | South Korea | 88,930,000 | USD | 0001140361-19-008097 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Southeast Asia | 70,860,000 | USD | 0001140361-19-008097 |
| Q1 2018Quarterly · 2018-03-31 | Product | Nu Skin | 386,450,000 | USD | 0001021561-18-000066 |
| Q1 2018Quarterly · 2018-03-31 | Product | Other Product Lines | 16,870,000 | USD | 0001021561-18-000066 |
| Q1 2018Quarterly · 2018-03-31 | Product | Pharmanex | 212,899,000 | USD | 0001021561-18-000066 |
| Q4 2017Quarterly · 2017-12-31 | Product | Nu Skin | 470,921,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Other Product Lines | 1,096,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Pharmanex | 194,184,000 | USD | Legacy provider |
| Q3 2017Quarterly · 2017-09-30 | Geography | Americas Pacific | 85,672,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Geography | China | 172,556,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Geography | EMEA | 40,133,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Geography | Hong Kong Taiwan | 41,050,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Geography | Japan | 62,513,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Geography | Other | 1,395,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Geography | South Korea | 89,238,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Geography | Southeast Asia | 71,141,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Product | Nu Skin | 338,305,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Product | Other Product Lines | 1,362,000 | USD | 0001140361-18-042662 |
| Q3 2017Quarterly · 2017-09-30 | Product | Pharmanex | 224,031,000 | USD | 0001140361-18-042662 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Americas Pacific | 82,997,000 | USD | 0001021561-18-000115 |
| Q2 2017Quarterly · 2017-06-30 | Geography | China | 172,098,000 | USD | 0001021561-18-000115 |
| Q2 2017Quarterly · 2017-06-30 | Geography | EMEA | 38,188,000 | USD | 0001021561-18-000115 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Hong Kong Taiwan | 43,071,000 | USD | 0001021561-18-000115 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Japan | 64,796,000 | USD | 0001021561-18-000115 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Other | 1,489,000 | USD | 0001021561-18-000115 |
| Q2 2017Quarterly · 2017-06-30 | Geography | South Korea | 86,917,000 | USD | 0001021561-18-000115 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Southeast Asia | 60,545,000 | USD | 0001021561-18-000115 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.